Marshall Fordyce
President and CEO at Vera Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Vera Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Vera Therapeutics Inc. | Open-market sale | โ1,000 | $40.78 | $40,776 |
| Jul 7, 2026 | Vera Therapeutics Inc. | Open-market sale | โ32,550 | $42.07 | $1,369,496 |
| Jul 7, 2026 | Vera Therapeutics Inc. | Open-market sale | โ10,500 | $42.86 | $450,007 |
| Jul 7, 2026 | Vera Therapeutics Inc. | Open-market sale | โ2,200 | $43.59 | $95,908 |
| Jun 23, 2026 | Vera Therapeutics Inc. | Open-market sale | โ18,412 | $37.93 | $698,367 |
| Jun 23, 2026 | Vera Therapeutics Inc. | Open-market sale | โ88 | $38.43 | $3,382 |
| May 12, 2026 | Vera Therapeutics Inc. | Open-market sale | โ14,219 | $36.64 | $520,984 |
| May 12, 2026 | Vera Therapeutics Inc. | Open-market sale | โ4,281 | $37.09 | $158,782 |
| Apr 14, 2026 | Vera Therapeutics Inc. | Open-market sale | โ14,130 | $43.66 | $616,916 |
| Apr 14, 2026 | Vera Therapeutics Inc. | Open-market sale | โ7,921 | $44.58 | $353,118 |
| Apr 14, 2026 | Vera Therapeutics Inc. | Open-market sale | โ900 | $45.51 | $40,959 |
| Feb 23, 2026 | Vera Therapeutics Inc. | Open-market sale | โ16,925 | $41.98 | $710,512 |
| Feb 4, 2026 | Vera Therapeutics Inc. | Grant or award | +68,800 | โ | โ |
| Feb 26, 2025 | Vera Therapeutics Inc. | Open-market sale | โ7,975 | $27.55 | $219,711 |
| Feb 26, 2025 | Vera Therapeutics Inc. | Open-market sale | โ1,100 | $28.32 | $31,152 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.